PET Detection of CCR2 in Human Atherosclerosis

Recruiting Phase 1 Interventional Study
Carotid Atherosclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 89
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Diagnostic
Participants needed
100 (estimated)
Sponsor
Washington University School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Normal Volunteers: 18-40 years of age, non smoker, no history of diabetes, hypertension, or hyperlipidemia. Patients: 50-89 years of age, adequate nutritional status, with or without smoking history, diabetes, hypertension, and hyperlipidema. Both asymptomatic and symptomatic pat…
Contacts

Kitty Harrison, BSN, RN

314-747-0183

harrisonk@mir.wustl.edu

CONTACT

Robert Gropler, M.D.

314-747-0183

groplerr@mir.wustl.edu

CONTACT